1. Home
  2. BHST vs OVID Comparison

BHST vs OVID Comparison

Compare BHST & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$5.30

Market Cap

137.1M

Sector

N/A

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHST
OVID
Founded
2007
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.1M
116.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BHST
OVID
Price
$5.30
$1.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$14.00
$3.50
AVG Volume (30 Days)
61.8K
1.5M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,720,000.00
$6,610,000.00
Revenue This Year
$116.40
$1,077.56
Revenue Next Year
$55.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.88
945.89
52 Week Low
$4.72
$0.24
52 Week High
$12.80
$2.01

Technical Indicators

Market Signals
Indicator
BHST
OVID
Relative Strength Index (RSI) 39.91 56.11
Support Level $5.07 $1.59
Resistance Level $5.43 $1.88
Average True Range (ATR) 0.43 0.13
MACD 0.08 0.00
Stochastic Oscillator 23.36 73.39

Price Performance

Historical Comparison
BHST
OVID

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: